Association of serotype-specific antibody concentrations and functional antibody titers with subsequent pneumococcal carriage in toddlers immunized with a 9-valent pneumococcal conjugate vaccine

Clinical and Vaccine Immunology

Volumn 19, Issue 1, 2012, Pages 96-99

  Simell, Birgit ^a   Nurkka, Anu ^a   Lahdenkari, Mika ^a   Givon Lavi, Noga ^b   Käyhty, Helena ^a   Dagan, Ron ^b   Jokinena, Jukka ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PNEUMOCOCCUS VACCINE;

ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CHILD; CONTROLLED STUDY; HUMAN; NASOPHARYNX; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; TODDLER; VIRUS CARRIER;

ANTIBODIES, BACTERIAL; BLOOD BACTERICIDAL ACTIVITY; CARRIER STATE; CHILD, PRESCHOOL; HUMANS; IMMUNOGLOBULIN G; INFANT; NASOPHARYNX; OPSONIN PROTEINS; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PREVALENCE; VACCINES, CONJUGATE;

EID: 84855666537     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.05369-11     Document Type: Article

References (20)

1. Burton RL, Nahm MH. 2006. Development and validation of a fourfold multiplexed opsonization assay (MOPA4) for pneumococcal antibodies. Clin. Vaccine Immunol. 13:1004-1009. (Pubitemid 44518968)
2. Cripps AW, Gleeson M, Clancy RL. 1991. Ontogeny of the mucosal immune response in children. Adv. Exp. Med. Biol. 310:87-92.
3. Dagan R, et al. 2005. Serum serotype-specific pneumococcal anticapsular immunoglobulin G concentrations after immunization with a 9-valent conjugate pneumococcal vaccine correlate with nasopharyngeal acquisition of pneumococcus. J. Infect. Dis. 192:367-376. (Pubitemid 41023114)
4. Dagan R, et al. 2002. Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers. J. Infect. Dis. 185:927-936. (Pubitemid 34274436)
5. Dagan R, et al. 1996. Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine. J. Infect. Dis. 174:1271-1278. (Pubitemid 26393906)
6. Dagan R, Muallem M, Melamed R, Leroy O, Yagupsky P. 1997. Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid. Pediatr. Infect. Dis. J. 16:1060-1064. (Pubitemid 27494964)
7. Fearon DT, Locksley RM. 1996. The instructive role of innate immunity in the acquired immune response. Science 272:50-53.
8. Henckaerts I, Durant N, De Grave D, Schuerman L, Poolman J. 2007. Validation of a routine opsonophagocytosis assay to predict invasive pneumococcal disease efficacy of conjugate vaccine in children. Vaccine 25:2518-2527. (Pubitemid 46366133)
9. Mbelle N, et al. 1999. Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine. J. Infect. Dis. 180:1171-1176. (Pubitemid 30070201)
10. McCool TL, Cate TR, Moy G, Weiser JN. 2002. The immune response to pneumococcal proteins during experimental human carriage. J. Exp. Med. 195:359-365. (Pubitemid 34461494)
11. McCool TL, Weiser JN. 2004. Limited role of antibody in clearance of Streptococcus pneumoniae in a murine model of colonization. Infect. Immun. 72:5807-5813. (Pubitemid 39303692)
12. Nieminen T, Kayhty H, Leroy O, Eskola J. 1999. Pneumococcal conjugate vaccination in toddlers: mucosal antibody response measured as circulating antibody-secreting cells and as salivary antibodies. Pediatr. Infect. Dis. J. 18:764-772. (Pubitemid 29428530)
13. Obaro SK, Adegbola RA, Banya WA, Greenwood BM. 1996. Carriage of pneumococci after pneumococcal vaccination. Lancet 348:271-272.
14. O'Brien KL, et al. 2007. Effect of pneumococcal conjugate vaccine on nasopharyngeal colonization among immunized and unimmunized children in a community-randomized trial. J. Infect. Dis. 196:1211-1220. (Pubitemid 47580276)
15. Quataert SA, et al. 1995. Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-S. Clin. Diagn. Lab. Immunol. 2:590-597.
16. Rothlein R, Springer TA. 1985. Complement receptor type three-dependent degradation of opsonized erythrocytes by mouse macrophages. J. Immunol. 135:2668-2672. (Pubitemid 16215866)
17. Simell B, Lahdenkari M, Reunanen A, Kayhty H, Vakevainen M. 2008. Effects of ageing and gender on naturally acquired antibodies to pneumococcal capsular polysaccharides and virulence-associated proteins. Clin. Vaccine Immunol. 15:1391-1397.
18. Simell B, et al. 2011. Aging reduces the functionality of anti-pneumococcal antibodies and the killing of Streptococcus pneumoniae by neutrophil phagocytosis. Vaccine 29:1929-1934.
19. Trzcinski K, Thompson C, Malley R, Lipsitch M. 2005. Antibodies to conserved pneumococcal antigens correlate with, but are not required for, protection against pneumococcal colonization induced by prior exposure in a mouse model. Infect. Immun. 73:7043-7046. (Pubitemid 41368878)
20. Walport MJ. 2001. Complement. N. Engl. J. Med. 344:1058-1066.